 The Star-Ledger - NJ.com | Bristol-Myers ends development of hepatitis C drug after test patient dies of ... Washington Post NEW YORK — Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure. The New York company said Thursday that it decided to discontinue development of ... Quick View Bristol-Myers drops hepatitis C drug after patient death |
